These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22539545)

  • 21. Risk factor status and vascular events in patients with symptomatic intracranial stenosis.
    Chaturvedi S; Turan TN; Lynn MJ; Kasner SE; Romano J; Cotsonis G; Frankel M; Chimowitz MI;
    Neurology; 2007 Nov; 69(22):2063-8. PubMed ID: 18040012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of intensive statin therapy in Chinese patients with atherosclerotic intracranial arterial stenosis: a single-center, randomized, single-blind, parallel-group study with one-year follow-up.
    Zhou P; Lu Z; Gao P; Wang P; Cao Z; Zhang G; Wang S; Feng Y; Wang P
    Clin Neurol Neurosurg; 2014 May; 120():6-13. PubMed ID: 24731567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of intracranial atherosclerotic disease under modern medical therapy.
    Leung TW; Wang L; Soo YO; Ip VH; Chan AY; Au LW; Fan FS; Lau AY; Leung H; Abrigo J; Wong A; Mok VC; Ng PW; Tsoi TH; Li SH; Man CB; Fong WC; Wong KS; Yu SC
    Ann Neurol; 2015 Mar; 77(3):478-86. PubMed ID: 25557926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early aggressive medical management for patients with symptomatic intracranial stenosis.
    Nahab F; Kingston C; Frankel MR; Dion JE; Cawley CM; Mitchell B; Hammonds LP; Ayala L; Tong FC
    J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):87-91. PubMed ID: 21795066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.
    Ovbiagele B; Saver JL; Lynn MJ; Chimowitz M;
    Neurology; 2006 May; 66(9):1344-9. PubMed ID: 16682665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.
    Zaidat OO; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Megerian JT; Lesko J; Pitzer P; Ramos J; Castonguay AC; Barnwell S; Smith WS; Gress DR;
    JAMA; 2015 Mar 24-31; 313(12):1240-8. PubMed ID: 25803346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study.
    Wang Y; Zhao X; Liu L; Soo YO; Pu Y; Pan Y; Wang Y; Zou X; Leung TW; Cai Y; Bai Q; Wu Y; Wang C; Pan X; Luo B; Wong KS;
    Stroke; 2014 Mar; 45(3):663-9. PubMed ID: 24481975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study.
    Mazighi M; Tanasescu R; Ducrocq X; Vicaut E; Bracard S; Houdart E; Woimant F
    Neurology; 2006 Apr; 66(8):1187-91. PubMed ID: 16636236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low HDL-C level is associated with the development of intracranial artery stenosis: analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) study.
    Qian Y; Pu Y; Liu L; Wang DZ; Zhao X; Wang C; Wang Y; Liu G; Pan Y; Wang Y
    PLoS One; 2013; 8(5):e64395. PubMed ID: 23691210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis.
    Qureshi AI; Kirmani JF; Hussein HM; Harris-Lane P; Divani AA; Suri MF; Janjua N; Alkawi A
    Neurosurgery; 2006 Nov; 59(5):1044-51; discussion 1051. PubMed ID: 17143239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up study of endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis trial.
    Mas JL; Arquizan C; Calvet D; Viguier A; Albucher JF; Piquet P; Garnier P; Viader F; Giroud M; Hosseini H; Hinzelin G; Favrole P; Hénon H; Neau JP; Ducrocq X; Padovani R; Milandre L; Rouanet F; Wolff V; Saudeau D; Mahagne MH; Sablot D; Amarenco P; Larrue V; Beyssen B; Leys D; Moulin T; Lièvre M; Chatellier G;
    Stroke; 2014 Sep; 45(9):2750-6. PubMed ID: 25082808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cilostazol on the progression and regression of symptomatic intracranial artery stenosis: it reduces the risk of ischemic stroke.
    Zhang WH; Cai FF; Wen ZM
    Neural Regen Res; 2015 Apr; 10(4):667-72. PubMed ID: 26170831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predictive value of nontraditional lipid parameters for intracranial and extracranial atherosclerotic stenosis: a hospital-based observational study in China.
    Yu S; Yan L; Yan J; Sun X; Fan M; Liu H; Li Y; Guo M
    Lipids Health Dis; 2023 Jan; 22(1):16. PubMed ID: 36709301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.
    Chan KL; Teo K; Dumesnil JG; Ni A; Tam J;
    Circulation; 2010 Jan; 121(2):306-14. PubMed ID: 20048204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.